Evidence map›Paper›PMID 26728082›Full record

ArticleScientific reports2016

How type 1 fimbriae help Escherichia coli to evade extracellular antibiotics.

Ima Avalos Vizcarra, Vahid Hosseini, Philip Kollmannsberger, Stefanie Meier, Stefan S Weber, Markus Arnoldini, Martin Ackermann, Viola Vogel

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Avian PathogenicVeterinary sciences · 2025
    Review
  3. Article
  4. Article
  5. Mechanisms ofMicroorganisms · 2025
    Article
  6. Biochemical characterization of theFrontiers in microbiology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ima Avalos VizcarraLaboratory of Applied Mechanobiology, Department of Health Sciences and Technology, ETH Zürich, 8093 Zürich, Switzerland.
Vahid HosseiniLaboratory of Applied Mechanobiology, Department of Health Sciences and Technology, ETH Zürich, 8093 Zürich, Switzerland.
Philip KollmannsbergerLaboratory of Applied Mechanobiology, Department of Health Sciences and Technology, ETH Zürich, 8093 Zürich, Switzerland.
Stefanie MeierLaboratory of Applied Mechanobiology, Department of Health Sciences and Technology, ETH Zürich, 8093 Zürich, Switzerland.
Stefan S WeberDepartment of Biology, ETH Zürich, 8093 Zürich, Switzerland.
Markus ArnoldiniDepartment of Environmental Systems Science, ETH Zürich, 8092 Zürich, Switzerland.
Martin AckermannDepartment of Environmental Systems Science, ETH Zürich, 8092 Zürich, Switzerland.
Viola VogelLaboratory of Applied Mechanobiology, Department of Health Sciences and Technology, ETH Zürich, 8093 Zürich, Switzerland.
ETH Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To survive antibiotics, bacteria use two different strategies: counteracting antibiotic effects by expression of resistance genes or evading their effects e.g. by persisting inside host cells. Since bacterial adhesins provide access to the shielded, intracellular niche and the adhesin type 1 fimbriae increases bacterial survival chances inside macrophages, we asked if fimbriae also influenced survival by antibiotic evasion. Combined gentamicin survival assays, flow cytometry, single cell microscopy and kinetic modeling of dose response curves showed that type 1 fimbriae increased the adhesion and internalization by macrophages. This was caused by strongly decreased off-rates and affected the number of intracellular bacteria but not the macrophage viability and morphology. Fimbriae thus promote antibiotic evasion which is particularly relevant in the context of chronic infections.

Indexed as

Fimbriae, BacterialAnimalsAnti-Bacterial AgentsBacterial AdhesionCell LineCell SurvivalDrug Resistance, BacterialEscherichia coliGene Expression Regulation, BacterialLysosomesMacrophagesMiceMicrobial ViabilityPhagocytosisPhenotypeAnti-Bacterial Agents

Identifiers

PMID26728082
PMCPMC4700443
OpenAlexW2229769038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.